UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000029935
Receipt number R000034198
Scientific Title Cerebral Blood Flow Measurement of MRI using PSO17 in Normal Subjects
Date of disclosure of the study information 2017/11/16
Last modified on 2018/11/13 10:40:16

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Cerebral Blood Flow Measurement of MRI using PSO17 in Normal Subjects

Acronym

Cerebral Blood Flow Measurement using PSO17

Scientific Title

Cerebral Blood Flow Measurement of MRI using PSO17 in Normal Subjects

Scientific Title:Acronym

Cerebral Blood Flow Measurement using PSO17

Region

Japan


Condition

Condition

brain infarction, brain tumor, epilepsy

Classification by specialty

Radiology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Comparison of PSO17 concentrations calculated by MRI signals with concentrations of arterial blood

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2

Explanatory

Developmental phase

Phase I


Assessment

Primary outcomes

Correlation of PSO17 concentrations between calculated by MRI signals and of arterial blood sampling

Key secondary outcomes

1) Qualitative comparison of PSO17 concentrations calculated by MR signals and of arterial blood sampling
2) vital signs (blood pressure, heart rate, and body temperature)
3) adverse effect


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Prevention

Type of intervention

Medicine

Interventions/Control_1

intravenous administration of PSO17 and arterial blood collection

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

65 years-old >

Gender

Male and Female

Key inclusion criteria

(1) healthy Japanese (20 - 65 years old)
(2) body weight < 80 kg
(3) informed consent is obtained

Key exclusion criteria

(1)metallic implant or claustrophobia
(2)blood flow abnormality by Allen test
(3)chronic disorders
(4)CNS, liver, kidney or heart disease
(5)acute infection before 30 days
(6)drug allergy
(7)chronic intake of drugs (> 30 days)
(8)other clinical trial within 90 days
(9)willing to have babies or during breast feeding

Target sample size

10


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Kohsuke Kudo

Organization

Hokkaido University Hospital

Division name

department of diagnostic and interventional radiology

Zip code


Address

Kita 14 Nishi 5, Kita-ku, Sapporo, Hokkaido

TEL

011-706-7779

Email

kkudo@huhp.hokudai.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Kohsuke Kudo

Organization

Hokkaido University Hospital

Division name

department of diagnostic and interventional radiology

Zip code


Address

Kita 14 Nishi 5, Kita-ku, Sapporo, Hokkaido

TEL

011-706-7779

Homepage URL


Email

kkudo@huhp.hokudai.ac.jp


Sponsor or person

Institute

Hokkaido University Hospital

Institute

Department

Personal name



Funding Source

Organization

Japan Agency for Medical Research and Development (AMED)/Translational Research Network Program

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

北海道大学病院


Other administrative information

Date of disclosure of the study information

2017 Year 11 Month 16 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2017 Year 11 Month 13 Day

Date of IRB


Anticipated trial start date

2017 Year 11 Month 13 Day

Last follow-up date

2018 Year 03 Month 31 Day

Date of closure to data entry

2018 Year 03 Month 31 Day

Date trial data considered complete

2019 Year 03 Month 31 Day

Date analysis concluded

2019 Year 03 Month 31 Day


Other

Other related information



Management information

Registered date

2017 Year 11 Month 12 Day

Last modified on

2018 Year 11 Month 13 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000034198


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name